| Literature DB >> 22235282 |
Takashi Kawahara1, Hiroki Ito, Hideyuki Terao, Takuya Yamagishi, Takehiko Ogawa, Hiroji Uemura, Yoshinobu Kubota, Junichi Matsuzaki.
Abstract
INTRODUCTION: We developed a method for ureteral stent removal in female patients that requires no cystoscopy or fluoroscopic guidance using a crochet hook. In addition, we also investigated the success rate, complications and pain associated with this procedure.Entities:
Mesh:
Year: 2012 PMID: 22235282 PMCID: PMC3250417 DOI: 10.1371/journal.pone.0029292
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Patient Characteristics.
| Variables | Number (%) or Median (mean ± SD) |
| |
| CH Removal | STD Removal | ||
| No. of stents | 56 | 50 | |
| No. of Pts. | 40 | 42 | |
| Age (yr) | 64 (62.5±16.2)) | 58.8 (58.1±15.3) | n.s. |
| Indication for stenting | |||
| Stone disease (%) | 56 (100%) | 50 (100%) | n.s. |
| Anesthesia/Sedation/Pain Killer | |||
| General anesthesia | 33 (58.9%) | 26 (52.0%) | n.s. |
| General and epidural anesthesia | 3 (5.4%) | 2 (4.0%) | |
| Spinal anesthesia | 1 (1.8%) | 2 (4.0%) | |
| Conscious Sedetion | 10 (17.6%) | 9 (18.0%) | |
| NSAIDs suppo. | 9 (16.1%) | 10 (20.0%) | |
| Side | |||
| Right (%) | 28 (50.0%) | 26 (52.0%) | n.s. |
| Left (%) | 28 (50.0%) | 24 (48.0%) | |
| Type of Stent | |||
| Loop (%) | 47 (83.9%) | 41 (82.0%) | n.s. |
| Double Pigtails (%) | 9 (16.1%) | 9 (18.0%) | |
NSAIDs: non steroidal anti infllamatory drugs.
Figure 1Crochet hook and the crochet hook technique.
a: Crochet hook. b: The hook was inserted into the bladder and used to draw out the distal end of the ureteral stent. (arrow) The distal end of the ureteral stent is grasped with the crochet hook and pulled out through the urethra.
Figure 2The images of this procedure.
These images show the crochet hook technique. However we did not use fluoroscopy in this study.
Summary of retrieval ureteral stent using crochet technique.
| Variables | Number (%) or Median (mean ± SD) |
| |
| CH Removal | STD Removal | ||
| No. of Stents | 56 | 50 | n.s. |
| No. of sessions | 3 (2.8±1.9) | 1 (1.1±0.3) | <0.001 |
| Success of remval | 47/56 (83.9%) | 46/50 (92.0%) | n.s. |
| Reason of irremovable | |||
| Encrustation | 2 (3.6%) | 2 (4.0%) | n.s. |
| Migration | 2 (3.6%) | 2 (4.0%) | n.s. |
| Complications | |||
| Active bleedings | 0 (0%) | 0 (0%) | n.s. |
| Hematuria | 30 (53.6%) | 27 (54.0%) | n.s. |
| Urinary infection | 1 (1.8%) | 2 (4.0%) | n.s. |
| Needed of additional procedure | |||
| Cystoscopy | 4 (7.1%) | - | |
| Fluoroscopy | 1 (1.8%) | - | |
VAPS: 5 grades visual analogue pain scale.
Figure 3A comparison of the success rate between the good and poor ureteral stent position groups.
The success rate of ureteral stent removal was significantly higher for stents in a good stent position than in a poor position. (p<0.001).
Patients Characteristics and clinical outcome in outpatient clinic.
| Variables | Number (%) or Median (mean ± SD) |
| |
| CH Removal | STD Removal | ||
| No. of Stents | 12 | 10 | |
| No. of Pts. | 12 | 10 | |
| Age (yr) | 64.5 (63.3±14.6) | 53.9 (52.9±16.4) | n.s. |
| Side | |||
| Right (%) | 5 (41.7%) | 5 (50.0%) | n.s. |
| Left (%) | 7 (58.3%) | 5 (50.0%) | |
| Indication for stenting | |||
| Stone disease (%) | 12 (100%) | 12 (100%) | n.s. |
| Anesthesia/Sedation/Pain Killer | |||
| Diclofenac sodium (50 mg) | 12 (100%) | 10 (100%) | n.s. |
| Success of ureteral stent removal | |||
| VAPS | 1 (1.4±0.7) | 2 (2.4±0.8) | 0.02 |
VAPS: 5 grades visual analogue pain scale.